Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Dimensional Fund Advisors
Austin,
Texas
| $1.78B | -$61.5M | 32 | 0.74% | Reduced |
|
| 27 |
Parnassus Investments
San Francisco,
California
| $1.7B | +$1.32M | 2 | 6.69% | Increased |
|
| 28 |
UBS Group
Zurich,
Switzerland
| $1.69B | +$30.4M | 71 | 0.7% | Increased |
|
| 29 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1.57B | +$21.6M | 68 | 1.01% | Increased |
|
| 30 |
ClearBridge Investments
New York
| $1.49B | +$32.3M | 15 | 1.38% | Increased |
|
| 31 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $1.49B | +$111M | 6 | 3.09% | Increased |
|
| 32 |
Pictet Asset Management (UK)
London,
United Kingdom
| $1.46B | +$168M | 12 | 3.76% | Increased |
|
| 33 |
Ameriprise
Minneapolis,
Minnesota
| $1.39B | -$231M | 26 | 0.64% | Reduced |
|
| 34 |
American Century Companies
Kansas City,
Missouri
| $1.31B | +$244M | 16 | 1.31% | Increased |
|
| 35 |
TIAA CREF Investment Management
New York
| $1.26B | -$78.2M | 41 | 0.83% | Reduced |
|
| 36 |
UBS AM
Chicago,
Illinois
| $1.22B | +$88.7M | 25 | 1.03% | Increased |
|
| 37 |
Jennison Associates
New York
| $1.21B | -$408M | 13 | 1.2% | Reduced |
|
| 38 |
Legal & General Group
London,
United Kingdom
| $1.18B | +$18.1M | 41 | 0.85% | Increased |
|
| 39 |
Brown Advisory
Baltimore,
Maryland
| $1.17B | -$44.3M | 12 | 3.7% | Reduced |
|
| 40 |
Charles Schwab
San Francisco,
California
| $1.17B | +$41M | 42 | 0.92% | Increased |
|
| 41 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.16B | +$92.6M | 61 | 0.51% | Increased |
|
| 42 |
Edgewood Management
Greenwich,
Connecticut
| $1.13B | +$9.03M | 1 | 4.92% | Increased |
|
| 43 |
D.E. Shaw & Co
New York
| $1.12B | +$39.1M | 36 | 1.55% | Increased |
|
| 44 |
Swiss National Bank
Zurich,
Switzerland
| $1,000M | +$36.6M | 32 | 1.08% | Increased |
|
| 45 |
OrbiMed
New York
| $983M | -$49.3M | 14 | 12.43% | Reduced |
|
| 46 |
Renaissance Technologies
New York
| $962M | +$351M | 45 | 1.06% | Increased |
|
| 47 |
Longview Partners
St Peter Port,
Guernsey
| $926M | +$59.8M | 1 | 4.85% | Increased |
|
| 48 |
New York State Common Retirement Fund
Albany,
New York
| $894M | +$3.12M | 42 | 1.08% | Increased |
|
| 49 |
Select Equity Group
New York
| $889M | -$26.2M | 4 | 7.08% | Reduced |
|
| 50 |
Allianz Asset Management
Munich,
Germany
| $883M | +$123M | 25 | 0.69% | Increased |
|